Novonesis (Novozymes) B (CHIX:NSISBC) Short-Term Debt : kr3,206 Mil (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Novonesis (Novozymes) B Short-Term Debt?

Novonesis (Novozymes) B's Short-Term Debt for the quarter that ended in Mar. 2025 was kr3,206 Mil.

Novonesis (Novozymes) B's quarterly Short-Term Debt declined from Jun. 2024 (kr6,842 Mil) to Dec. 2024 (kr1,987 Mil) but then increased from Dec. 2024 (kr1,987 Mil) to Mar. 2025 (kr3,206 Mil).

Novonesis (Novozymes) B's annual Short-Term Debt increased from Dec. 2022 (kr2,814 Mil) to Dec. 2023 (kr3,039 Mil) but then declined from Dec. 2023 (kr3,039 Mil) to Dec. 2024 (kr1,987 Mil).

Novonesis (Novozymes) B Short-Term Debt Historical Data

The historical data trend for Novonesis (Novozymes) B's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Short-Term Debt Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

2,028.70

2,813.69

3,039.37

1,986.73

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
Short-Term Debt	Get a 7-Day Free Trial															3,039.37	-	6,841.80	1,986.73	3,206.50

Novonesis (Novozymes) B Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Novonesis (Novozymes) B Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (CHIX:NSISBc) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA 0Q4U:UK NSIS B:Denmark NZM:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines